Volume 2
Buch, Englisch, 488 Seiten, Format (B × H): 155 mm x 235 mm, Gewicht: 756 g
ISBN: 978-981-329-368-7
Verlag: Springer Nature Singapore
Zielgruppe
Research
Autoren/Hrsg.
Fachgebiete
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Vorklinische Medizin: Grundlagenfächer Biochemie (med.)
- Technische Wissenschaften Sonstige Technologien | Angewandte Technik Medizintechnik, Biomedizintechnik
- Naturwissenschaften Biowissenschaften Zellbiologie
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Pneumologie, Atmung, Asthma
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Medizintechnik, Biomedizintechnik, Medizinische Werkstoffe
Weitere Infos & Material
Part A.- Chapter 1. The effects of oxidative stress on the pulmonary surfactant and the role of lipids in this scenario.- Chapter 2. Oxidative stress in experimental models of acute lung injury.- Chapter 3. Potential of mesenchymal stem cells in modulating oxidative stress in the management of lung diseases.- Chapter 4. Role of NADPH oxidase induced oxidative stress in matrix metalloprotease-mediated lung diseases.- Chapter 5. Oxidative stress mechanisms in the pathogenesis of environmental lung diseases.- Part B.- Chapter 6. Oxidative stress induced mitochondrial dysfunction and asthma.- Chapter 7. Regulation of antioxidant Nrf2 signaling, an important pathway in COPD.- Chapter 8. Role of smoke-induced oxidative stress in pathogenesis of chronic obstructive pulmonary disease.- Chapter 9. Oxidative stress in obstructive and restrictive lung diseases.- Chapter 10. The use of ozone as redox modulator in the treatment of the chronic obstructive pulmonary disease.- Chapter 11. TRP channels, oxidative stress and chronic obstructive pulmonary disease.- Chapter 12. Paraquat induced oxidative stress and lung inflammation.- Chapter 13. Environmental, occupational and cancer drug induced oxidative stress in lung fibrosis.- Part C.- Chapter 14. Respiratory syncytial virus-induced oxidative stress in lung pathogenesis.- Chapter 15. Reactive oxygen species: Friends or foes of lung cancer?.- Chapter 16. Roles of long non-coding RNAs in lung cancer.- Chapter 17. modulator of therapeutic response in non small cell lung carcinoma.- Chapter 18. old story, new modalities!.Part D.- Chapter 19. Oxidative stress and therapeutic development in lung cancer.- Chapter 20. Regulation of oxidative stress by nitric oxide defines lung development and Diseases.- Chapter 21. Epidermal growth factor receptor: promising targets for non-small cell lung cancer.- Chapter 22. Oxygenated lipid products in COPD and asthma: a clinical picture.